News

October 27, 2020

BioSkryb’s Novel PTA Technology for High-Quality Single-Cell Whole Genome Amplification Will Be Commercially Available for the First Time at ASHG 2020

Research being presented at ASHG 2020 to support use of PTA technology in the study of genetic variants that contribute to drug resistance in cancer treatment October 26, 2020 09:00 AM Eastern Daylight Time DURHAM, N.C.–(BUSINESS WIRE)–BioSkryb, Inc., a developer of genomic amplification technologies, today announced the commercial launch...

August 3, 2020

BioSkryb Launches Researcher Early Access Program for Genomic Amplification Technology

DURHAM, NC, Aug. 3, 2020 — BioSkryb, Inc. (“BioSkryb”), a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced that it has launched an Early Access Program (EAP) for researchers to test its proprietary genomic amplification technology (Primary Template-directed Amplification or PTA)....

June 22, 2020

BioSkryb and St. Jude Children’s Research Hospital Partner

Single Cell Genome Sequencing Company BioSkryb and St. Jude Children’s Research Hospital Partner to Develop Clinical Diagnostic Solutions to Identify Resistant Cancer Cells as Patients Undergo Treatment DURHAM, N.C., June 22, 2020 /PRNewswire/ — BioSkryb, a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene...

April 21, 2020

Addressing Coronavirus Testing Bottleneck, Scientists Turn to RNA-Extraction-Free PCR

Apr 20, 2020 | Julia Karow NEW YORK – Two months into the COVID-19 pandemic, the number of SARS-CoV-2 molecular diagnostic tests across the US remains woefully inadequate. According to the COVID Tracking Project, a volunteer effort to track testing across the country headed by The Atlantic, more than...

April 14, 2020

The Genesis of Genotypes

Tuesday, April 14, 2020 | Mike May Delving into a single cell’s DNA reveals a reductionist’s dream. By unraveling the identity and order of nucleic acids in just one cell, scientists can explore some of the most basic biology, and clinicians can better understand and treat more diseases. With...

February 24, 2020

BioSkryb Partners with Argonaut Manufacturing Services to Accelerate Production of Key Genomic Amplification Products

DURHAM, February 24, 2020 — BioSkryb, Inc., a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced that it is partnering with Argonaut Manufacturing Services, a contract manufacturing organization (CMO) serving the life science and molecular diagnostics markets, to scale production of...

January 23, 2020

Startup BioSkryb Eyes Oncology Applications for Single-Cell DNA Sequencing

Jan 23, 2020 | Andrew P. Han NEW YORK – A North Carolina startup is hoping to take genomic research to the single-cell level, with a new whole-genome amplification technology. “I haven’t done bulk RNA sequencing in probably five years,” said Charles Gawad, cofounder of Durham, North Carolina-based BioSkryb...

January 9, 2020

Single Cell Genome Sequencing Company BioSkryb Raises $11.5M in Seed Funding Round

DURHAM – BioSkryb, a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced it raised $11.5 million in new funding. This Seed round was led by venture capital firm Anzu Partners and included the law firm Wilson Sonsini Goodrich & Rosati. The...